VNDA - Vanda Pharmaceuticals GAAP EPS of -$0.04 beats by $0.05 revenue of $45.27M beats by $8.27M
2024-02-07 16:14:15 ET
More on Vanda Pharmaceuticals
- Vanda Pharmaceuticals: FDA Approvals On Deck In 2024 Makes This A Must Watch
- Vanda updates on FDA review for Hetlioz label expansion
- Fed court allows Vanda lawsuit against FDA to move forward
- Seeking Alpha’s Quant Rating on Vanda Pharmaceuticals
- Historical earnings data for Vanda Pharmaceuticals